Medicare Enrolled

Dr. John Vargas, D.O.

Dermatology · Midland, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
2525 WASHINGTON ST, Midland, MI 48642
9898328803
In practice since 2007 (18 years)
NPI: 1063692044 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vargas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vargas? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Vargas

Dr. John Vargas is a dermatology specialist in Midland, MI, with 18 years of NPI registration. Based on federal Medicare data, Dr. Vargas performed 1,363 Medicare services across 330 unique beneficiaries.

Between the years covered by Open Payments, Dr. Vargas received a total of $19,086 from 60 pharmaceutical and/or device companies across 1079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in dermatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Vargas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 20% volume in MI $19,086 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,363
Medicare services
Top 20% in MI for dermatology
330
Unique beneficiaries
$46
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~76 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
1,056 $55 $106
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
132 $9 $36
Smoking cessation counseling, 4-10 minutes
A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation.
97 $14 $30
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
21 $61 $157
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
20 $3 $5
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
13 $19 $110
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
12 $19 $56
Annual depression screening 12 $17 $25
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$19,086
Total received (2018-2024)
Avg $2,727/year across 7 years
Top 1% in MI for dermatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
1,079
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,894 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$192 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,947
2023
$2,590
2022
$2,643
2021
$3,459
2020
$2,117
2019
$2,852
2018
$2,477

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$407
Otsuka America Pharmaceutical, Inc.
$272
Sumitomo Pharma America, Inc.
$248
Vanda Pharmaceuticals Inc.
$238
Grifols USA, LLC
$221
Lundbeck LLC
$203
AstraZeneca Pharmaceuticals LP
$196
GlaxoSmithKline, LLC.
$148
Novo Nordisk Inc
$139
Axsome Therapeutics, Inc.
$105
Lilly USA, LLC
$101
Corium, LLC
$97
Amgen Inc.
$94
Mylan Specialty L.P.
$83
Neurocrine Biosciences, Inc.
$70
Xeris Pharmaceuticals, Inc.
$69
Supernus Pharmaceuticals, Inc.
$64
Exact Sciences Corporation
$52
Phathom Pharmaceuticals, Inc.
$36
E.R. Squibb & Sons, L.L.C.
$31
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Astellas Pharma US Inc
$18
PFIZER INC.
$16
Novartis Pharmaceuticals Corporation
$15
Top 3 companies account for 31.4% of 2024 payments
All-time payments by company (2018-2024) ›
Otsuka America Pharmaceutical, Inc.
$2,279
Supernus Pharmaceuticals, Inc.
$1,550
PFIZER INC.
$1,371
GlaxoSmithKline, LLC.
$1,147
Grifols USA, LLC
$921
Amgen Inc.
$776
Sunovion Pharmaceuticals Inc.
$759
ITI, Inc.
$755
ABBVIE INC.
$676
Takeda Pharmaceuticals U.S.A., Inc.
$595
AbbVie Inc.
$588
Lilly USA, LLC
$560
Axsome Therapeutics, Inc.
$459
AstraZeneca Pharmaceuticals LP
$443
Novo Nordisk Inc
$436
Boehringer Ingelheim Pharmaceuticals, Inc.
$422
Lundbeck LLC
$391
Neurocrine Biosciences, Inc.
$385
Novartis Pharmaceuticals Corporation
$381
Sumitomo Pharma America, Inc.
$380
Bayer HealthCare Pharmaceuticals Inc.
$321
Teva Pharmaceuticals USA, Inc.
$302
Allergan Inc.
$284
Mylan Specialty L.P.
$281
SANOFI-AVENTIS U.S. LLC
$262
Xeris Pharmaceuticals, Inc.
$243
Vanda Pharmaceuticals Inc.
$238
Esperion Therapeutics, Inc.
$216
Corium, LLC
$197
IDORSIA PHARMACEUTICALS US INC
$187
E.R. Squibb & Sons, L.L.C.
$153
Exact Sciences Corporation
$119
Amarin Pharma Inc.
$111
Horizon Therapeutics plc
$101
Daiichi Sankyo Inc.
$85
Horizon Pharma plc
$69
Janssen Pharmaceuticals, Inc
$68
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$64
Abbott Laboratories
$60
Biohaven Pharmaceuticals, Inc.
$41
Phathom Pharmaceuticals, Inc.
$36
Biohaven Pharmaceutical Holding Company Ltd.
$36
RedHill Biopharma Inc.
$35
Mallinckrodt LLC
$32
Kowa Pharmaceuticals America, Inc.
$30
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)
$21
Hikma Pharmaceuticals USA
$21
Insulet Corporation
$20
Resmed Corp
$19
AbbVie, Inc.
$18
Astellas Pharma US Inc
$18
Eisai Inc.
$17
Bayer Healthcare Pharmaceuticals Inc.
$16
Merck Sharp & Dohme Corporation
$14
Allergan, Inc.
$13
Dexcom, Inc.
$13
Corcept Therapeutics
$12
DEXCOM, INC.
$12
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$12
Medtronic MiniMed, Inc.
$11
Top 3 companies account for 27.2% of all-time payments
Associated products mentioned in payments ›
ABILIFY MAINTENA · ACTHAR · ADVAIR · AIMOVIG · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · AREXVY · AUSTEDO · AZSTARYS · Adempas · Aimovig · AirSense · Amitiza · Auvelity · Azstarys · BASAGLAR · BELBUCA · BREZTRI · BREZTRI AEROSPHERE · BRINTELLIX · CAPLYTA · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · EVENITY · FANAPT · FARXIGA · FASENRA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GEMTESA · GVOKE HYPOPEN · GVOKE PFS · HETLIOZ · INGREZZA · JANUVIA · JARDIANCE · KRYSTEXXA · Kerendia · Kloxxado · Korlym · LATUDA · LEQVIO · LINZESS · LONHALA MAGNAIR · LYRICA · Minimed 670G System · Morphabond ER · Movantik · NEXLIZET · NURTEC ODT · OXTELLAR XR · Omnipod · Otezla · Ozempic · PREMARIN · PREVNAR - 13 · PREVNAR 13 · Perforomist · Prolastin-C · Prolastin-C Liquid · Prolia · QELBREE · QULIPTA · QUVIVIQ · QVAR · Qelbree · REXULTI · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · SYNTHROID · Synthroid · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · TRUMENBA · Tresiba · Trintellix · UBRELVY · UTIBRON · UTIBRON NEOHALER · Uloric · Utibron · VOQUEZNA · VRAYLAR · VYNDAMAX · VYVANSE · Vascepa · Veozah · Victoza · Vyvanse · XARELTO · XIFAXAN · XIFIXAN · Xultophy 100/3.6 · YUPELRI · Yupelri · ZEPBOUND
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for dermatology in MI.

Looking for a dermatology specialist in Midland?
Compare dermatologists in the Midland area by procedure volume, costs, and industry payment transparency.
Browse dermatologists nearby

Geographic Context

Dermatologists within 10 mi
8
Per 100K population
9.6
County median income
$77,538
Nearest hospital
HEALTHSOURCE SAGINAW
19.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Vargas is a clinical cardiology specialist, with above-average Medicare volume (top 20% in MI), with low-engagement industry engagement in the top 1% of MI peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Vargas experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Vargas performed 1,056 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vargas receive payments from pharmaceutical companies?
Yes. Dr. Vargas received a total of $19,086 from 60 companies across 1,079 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vargas's costs compare to other dermatologists in Midland?
Dr. Vargas's average Medicare payment per service is $46. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vargas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →